Regulatory execution is emerging as one of the most important gating factors for commercializing advanced nuclear technologies, where licensing timelines often determine whether projects advance or stall. For Oklo Inc. (OKLO), progress with the U.S. Nuclear Regulatory Commission (“NRC”) is central to its strategy to deploy fast fission powerhouses at scale. By prioritizing early and structured regulatory engagement, the company is working to reduce uncertainty and create clearer visibility around deployment schedules, a critical differentiator in a capital-intensive and highly regulated industry.
OKLO has elected to pursue a combined license pathway under Title 10 of the Code of Federal Regulations Part 52 rather than the traditional two-step approach used for legacy reactors. This approach integrates construction and operating approvals into a single application, aligning with OKLO’s model of designing, building and operating its own facilities. The submission of the first custom combined license application for an advanced fission reactor establishes an important regulatory precedent, positioning that application as a reference that can be reused to narrow the scope of future reviews.
This approach allows OKLO to reuse key regulatory documents, such as safety and design reports, which can shorten review times for later projects. Progress at the Aurora-INL site supports this effort, with early readiness checks completed and the license application formally under review. OKLO’s passive safety features further ease regulatory review. Together, these steps point to improving regulatory momentum and clearer timelines ahead.
How Nuclear Peers Are Approaching Fuel and Licensing Risk
NuScale Power (SMR) has been deeply involved in the U.S. nuclear regulatory process for many years. SMR worked closely with the NRC to secure design certification and later standard design approval for its small modular reactor. NuScale continues to engage regulators as customers move toward construction and operating licenses. NuScale views regulatory engagement as essential to commercial deployment and long-term credibility.
Meanwhile, NANO Nuclear Energy (NNE) is actively navigating early-stage regulatory pathways for its advanced microreactor designs. NANO Nuclear engages with the NRC through pre-application meetings, topical reports, and fuel qualification reviews. The company has also hired former regulators to guide licensing strategy. NANO Nuclear sees early and ongoing regulatory coordination as critical to reducing risk and supporting future construction permit applications.
The Zacks Rundown on OKLO
Shares of Oklo Inc. have surged nearly 250% so far this year, breezing past the industry's growth.
Image Source: Zacks Investment Research
OKLO currently has an average brokerage recommendation (ABR) of 2.05 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 19 brokerage firms.
Image Source: Zacks Investment Research
See how the Zacks Consensus Estimate for OKLO’s earnings has been revised over the past 30 days.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>NuScale Power Corporation (SMR) : Free Stock Analysis Report
Nano Nuclear Energy Inc. (NNE) : Free Stock Analysis Report
Oklo Inc. (OKLO) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
